Jason Gorman

Jason Gorman

Auto-generated profile, based on publicly available information

Jason Gorman

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
LLLihong Liu
Lihong Liu
PWPengfei Wang
Pengfei Wang
MNManoj S Nair
Manoj S Nair
JYJian Yu
Jian Yu
MRMicah Rapp
Micah Rapp
DHDavid Ho
David Ho

23 November 2011 in Nature
Verified
Journal Article
Closed access
PDF file
JMJason McLellan
Jason McLellan
MPMarie Pancera
Marie Pancera
CCChris Carrico
Chris Carrico
JGJason Gorman
Jason Gorman
JJJean-Philippe Julien
Jean-Philippe Julien
PKPeter D. Kwong
Peter D. Kwong

2 March 2014 in Nature
Verified
Journal Article
Closed access
PDF file
NDNicole A. Doria-Rose
Nicole A. Doria-Rose
CSChaim A. Schramm
Chaim A. Schramm
JGJason Gorman
Jason Gorman
PMPenny Moore
Penny Moore
JBJinal N. Bhiman
Jinal N. Bhiman
JMJohn R. Mascola
John R. Mascola

8 October 2014 in Nature
Verified
Journal Article
Open access
PDF file
MPMarie Pancera
Marie Pancera
TZTongqing Zhou
Tongqing Zhou
ADAliaksandr Druz
Aliaksandr Druz
IGIvelin S. Georgiev
Ivelin S. Georgiev
CSCinque Soto
Cinque Soto
PKPeter D. Kwong
Peter D. Kwong
The human immunodeficiency virus type 1 (HIV-1) envelope (Env) spike, comprising three gp120 and three gp41 subunits, is a conformational machine that facilitates HIV-1 entry by rearranging from a mature unliganded state, through receptor-bound intermediates, to a post-fusion state. As the sole viral antigen on the HIV-1 virion surface, Env is both the target of neutralizing antibodies and a focus of vaccine efforts. Here we report the structure at 3.5 Å resolution for an HIV-1 Env trimer captured in a mature closed state by antibodies PGT122 and 35O22. This structure reveals the pre-fusion conformation of gp41, indicates rearrangements needed for fusion activation, and defines parameters of immune evasion and immune recognition. Pre-fusion gp41 encircles amino- and carboxy-terminal strands of gp120 with four helices that form a membrane-proximal collar, fastened by insertion of a fusion peptide-proximal methionine into a gp41-tryptophan clasp. Spike rearrangements required for entry involve opening the clasp and expelling the termini. N-linked glycosylation and sequence-variable regions cover the pre-fusion closed spike; we used chronic cohorts to map the prevalence and location of effective HIV-1-neutralizing responses, which were distinguished by their recognition of N-linked glycan and tolerance for epitope-sequence variation.

7 November 2014 in Science
Verified
Journal Article
Closed access
PDF file
JMJames Munro
James Munro
JGJason Gorman
Jason Gorman
XMXiaochu Ma
Xiaochu Ma
ZZZhou Zhou
Zhou Zhou
JAJames Arthos
James Arthos
WMWalther Mothes
Walther Mothes
HIV's shape-shifting envelope protein: HIV's envelope protein (Env) coats virus particles and allows HIV to enter host cells. HIV entry is highly dynamic. Env proteins work in groups of three (called trimers), which bind to the viral receptor and co-receptor, both expressed by host cells. Viral receptor binding causes a structural rearrangement in the trimer that allows for co-receptor binding and finally, viral entry. To visualize dynamic changes in Env conformation during viral entry, Munro et al. added differently colored fluorescent tags to two different regions of individual HIV trimers. Single-molecule fluorescence resonance entry transfer revealed three distinct Env conformations before cell entry. Occupation of particular conformations depended on host receptor binding. Science , this issue p. 759

22 June 2015 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
PKPeter Kwong
Peter Kwong
MPMarie Pancera
Marie Pancera
PAPriyamvada Acharya
Priyamvada Acharya
IGIvelin S Georgiev
Ivelin S Georgiev
ECEmma T Crooks
Emma T Crooks
PKPeter D Kwong
Peter D Kwong
The structure of the ligand-free HIV-1–Env trimer allows conformational fixation of Env and generation of an antigen that binds CD4 with high affinity and is recognized by broadly neutralizing antibodies but not poorly neutralizing ones. As the sole viral antigen on the HIV-1–virion surface, trimeric Env is a focus of vaccine efforts. Here we present the structure of the ligand-free HIV-1–Env trimer, fix its conformation and determine its receptor interactions. Epitope analyses revealed trimeric ligand-free Env to be structurally compatible with broadly neutralizing antibodies but not poorly neutralizing ones. We coupled these compatibility considerations with binding antigenicity to engineer conformationally fixed Envs, including a 201C 433C (DS) variant specifically recognized by broadly neutralizing antibodies. DS-Env retained nanomolar affinity for the CD4 receptor, with which it formed an asymmetric intermediate: a closed trimer bound by a single CD4 without the typical antigenic hallmarks of CD4 induction. Antigenicity-guided structural design can thus be used both to delineate mechanism and to fix conformation, with DS-Env trimers in virus-like-particle and soluble formats providing a new generation of vaccine antigens.